• Bell Potter says this ASX healthcare share could rise 200%+

    Happy investor on tablet with finance graphs rising in overlay.

    Saluda Medical Inc (ASX: SLD) shares had a day to forget on Friday.

    The ASX healthcare share ended the week with a 25% decline to 48 cents after the market responded negatively to its FY 2026 results.

    While this is disappointing, the team at Bell Potter believes it could have created a very attractive buying opportunity.

    What is the broker saying?

    Saluda Medical is a medical device company commercialising spinal cord stimulation (SCS) therapy. 

    Bell Potter notes the ASX healthcare share reported higher than expected operating expenses in FY 2026, which resulted in a sizeable adjusted EBITDA loss. It said:

    Revenue was pre-released at the Q4 update, increasing +28% for the full year with a particularly strong 2H (up +38% on pcp). Gross margin of 48.9% was ahead of our forecast (48.5%) and improved +2.3% yoy. Opex was above our forecast, resulting in loss at EBITDA (adjusted) of -$113.7m albeit still coming better than Prospectus guidance of -$114.7m.

    However, there were positives. It adds:

    In SLD’s first full-year result since listing, management has beaten each key metric guided to at the time of the IPO (revenue, EBITDA loss, cashflow). Closing cash balance was $116m and excludes $25m of undrawn debt available under the Perceptive loan available to be drawn down in 1H FY27.

    Looking ahead, Bell Potter points out that management is guiding to more strong top line growth and another EBITDA loss. It adds:

    The company provided four key FY27 guidance statements: (1) revenue growth of 25-35% ($113m-122m); (2) gross margin 50%-52% while reiterating the longer-term target of ‘mid-60s’ once the next generation IPG and percutaneous leads are submitted to and approved by the FDA (launch guided to CY27); (3) adjusted EBITDA loss $101-95m; and (4) revenue growth to outpace opex growth. 

    Big potential returns

    Bell Potter remains very positive on the ASX healthcare share.

    In response to its results, the broker has retained its buy rating and $1.60 price target on its shares.

    Based on its current share price, this implies potential upside of approximately 230% for investors over the next 12 months.

    Speaking about its buy thesis, Bell Potter said:

    SLD’s US commercial execution continues to impress and accelerated considerably in recent quarters (34% US growth in Q3, 45% in Q4). Tailwinds continue to build following FDA approval of SLD’s paddle lead in June and ~40% of the current sales force expected to complete training in FY27 and contribute to revenue generation. Real-world data continues to affirm Evoke’s value proposition: greater efficacy durability means fewer reprogramming requirements and therefore greater revenue/rep compared to conventional devices.

    The post Bell Potter says this ASX healthcare share could rise 200%+ appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Saluda Medical right now?

    Before you buy Saluda Medical shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Saluda Medical wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Wildcat Resources delivers more high-grade lithium drill results

    Two miners laughing and having fun while using smart phone during their coffee break.

    The Wildcat Resources Ltd (ASX: WC8) share price is in focus today after the company reported another round of strong lithium drill results at its Bolt Cutter Central and Tabba Tabba projects in WA. Recent highlights include intersections of 18 metres at 1.1% Li₂O at Bolt Cutter Central and 25.1 metres at 1.2% Li₂O at Tabba Tabba.

    What did Wildcat Resources report?

    • Multiple high-grade lithium drill intersections across Bolt Cutter Central and Tabba Tabba, including 16m @ 1.5% Li₂O and 13.9m @ 2.0% Li₂O.
    • The Bolt Cutter Central mineralised system now extends over approximately 2.3km by 0.8km and remains open in most directions.
    • Resource modelling at Bolt Cutter Central is underway, with a maiden Mineral Resource Estimate targeted for Q4 2026.
    • Tabba Tabba’s Definitive Feasibility Study (DFS) remains on track for completion in the second half of 2026.
    • Wildcat finished the quarter with $37.2 million cash at 30 June 2026.

    What else do investors need to know?

    Wildcat’s latest drilling at both projects confirmed the strength and continuity of lithium-bearing pegmatites, with mineralisation both close to surface and at depth. At Bolt Cutter Central, promising results from newly drilled zones have extended known mineralisation, pointing to more exploration upside.

    Meanwhile, Wildcat has completed the acquisition of additional LCT rights over ground abutting the Tabba Tabba mining leases, tripling its lithium exploration strike length. Planning for future drill targets in the expanded area is well advanced.

    What’s next for Wildcat Resources?

    Looking ahead, the company’s immediate focus is on delivering a maiden Mineral Resource Estimate for Bolt Cutter Central and advancing technical studies at Tabba Tabba. Ongoing exploration and infill drilling are planned across both project areas to support resource growth and project development.

    The Tabba Tabba DFS is set for release in the second half of 2026, and Wildcat is targeting key new drill regions for further resource upgrades in the months ahead.

    Wildcat Resources share price snapshot

    Over the past 12 months, Wildcat Resources shares have soared more than 100%, far outpacing the All Ordinaries Index (ASX: XAO).

    View Original Announcement

    The post Wildcat Resources delivers more high-grade lithium drill results appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Wildcat Resources right now?

    Before you buy Wildcat Resources shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wildcat Resources wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • 3 ASX dividend shares raising dividends like clockwork

    Increasing white bar graph with a rising arrow on an orange background.

    I think one of the most important elements of a good ASX dividend share is its ability to provide regular dividend growth. If I’m relying on passive income payments, I’d want to choose shares that are highly likely to continue delivering dividends.

    Preferably, I’d want to own investments that are likely to regularly increase the payouts to help offset inflation and hopefully grow faster than inflation.

    Let’s look at three businesses that have increasingly excellent track records of dividend growth.

    APA Group (ASX: APA)

    APA Group is one of the largest energy infrastructure businesses on the ASX. It’s invested in various aspects of Australia’s energy system including a huge network of gas pipelines, gas storage and processing, gas-powered energy generation, solar farms, wind farms and batteries.

    It pays for its impressive distribution from the cash flow that its portfolio of energy assets produces. That cash flow is steadily rising amid additions of new energy assets over the years via acquisitions and project builds, as well as inflation-linked revenue increases.

    The ASX dividend share has increased its payout every year for more than 20 years in a row, which is an excellent record of consistency.

    It expects to increase its annual distribution to 59 cents per security in FY27, adding to its record. This translates into a forward distribution yield of 5.5%.  

    Future Generation Global Ltd (ASX: FGG)

    Future Generation Global is a listed investment company (LIC) that gives investors exposure to a portfolio of global stocks and also compelling philanthropic efforts.

    It’s invested in a portfolio of funds from more than a dozen fund managers focused on global shares, who all work for free. With those investments, there are more than 3,700 underlying shares in the portfolio, which is great diversification.

    The shares come from across the world, including North America, the UK, Europe, Asia, other developed markets and emerging markets.

    The ASX dividend share’s investment returns help pay for a growing dividend, which has increased every year since FY19, so we’re already at several years of consecutive payout growth.

    It expects to pay an annual dividend of 8.4 cents per share in FY26, which translates into a grossed-up dividend yield of 7.4%, including franking credits.

    Washington H. Soul Pattinson and Co. Ltd (ASX: SOL)

    Soul Patts is another leading investment business on the ASX. It’s an investment house that has been listed for more than 120 years.

    The beauty of its strategy is that it’s invested in a variety of largely uncorrelated assets that can all generate cash flow in most economic conditions and help the company fund its market-leading dividend.

    The ASX dividend share is the leader on the ASX in terms of the number of consecutive years it has increased its dividend. The regular dividend has increased every year since 1998. It’s not far off 30 years of consecutive dividend growth!

    With a regularly expanding portfolio of new investments – along with organic growth of existing investments – I think it’s likely to continue hiking its dividend in the years ahead.

    It currently has a grossed-up dividend yield of 3.4%, including franking credits, though I expect the yield for the next 12 months will include a dividend hike.

    The post 3 ASX dividend shares raising dividends like clockwork appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Apa Group right now?

    Before you buy Apa Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Apa Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has positions in Future Generation Global and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has positions in and has recommended Apa Group and Washington H. Soul Pattinson and Company Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • The ASX 200 blue chip shares I would buy with $5,000 after the market crash

  • The list of market resources pinned to the top of the sub has been updated!

  • Financial statement inaccuracy

  • PFE | Pfizer and German partner BioNTech SE said Tuesday they’ve begun delivering doses of their coronavirus vaccine to US candidates with trials in Germany already underway.